Janux Therapeutics Inc (JANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 8,897 | 1,252 | 2,461 | 2,517 | 1,057 |
| Gross Profit | 8,897 | 1,252 | 2,461 | 2,517 | 1,057 |
| Operating Expenses | 22,719 | 21,413 | 18,598 | 18,330 | 21,805 |
| Operating Income | -13,822 | -20,161 | -16,137 | -15,813 | -20,748 |
| Other Income | 7,863 | 5,401 | 4,379 | 4,245 | 3,240 |
| Pre-tax Income | -5,959 | -14,760 | -11,758 | -11,568 | -17,508 |
| Net Income Continuous | -5,959 | -14,760 | -11,758 | -11,568 | -17,508 |
| Net Income | $-5,959 | $-14,760 | $-11,758 | $-11,568 | $-17,508 |
| EPS Basic Total Ops | -0.11 | -0.30 | -0.23 | -0.25 | -0.42 |
| EPS Basic Continuous Ops | -0.11 | -0.30 | -0.23 | -0.25 | -0.42 |
| EPS Diluted Total Ops | -0.11 | -0.30 | -0.23 | -0.25 | -0.42 |
| EPS Diluted Continuous Ops | -0.11 | -0.30 | -0.23 | -0.25 | -0.42 |
| EPS Diluted Before Non-Recurring Items | -0.11 | -0.30 | -0.25 | N/A | N/A |
| EBITDA(a) | $-16,289 | $-21,416 | $-17,667 | $-17,421 | $-22,118 |